147 related articles for article (PubMed ID: 33083460)
21. Aryl Hydrocarbon Receptor Activity in Hepatocytes Sensitizes to Hyperacute Acetaminophen-Induced Hepatotoxicity in Mice.
Schuran FA; Lommetz C; Steudter A; Ghallab A; Wieschendorf B; Schwinge D; Zuehlke S; Reinders J; Heeren J; Lohse AW; Schramm C; Herkel J; Carambia A
Cell Mol Gastroenterol Hepatol; 2021; 11(2):371-388. PubMed ID: 32932016
[TBL] [Abstract][Full Text] [Related]
22. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis.
Quintana FJ; Murugaiyan G; Farez MF; Mitsdoerffer M; Tukpah AM; Burns EJ; Weiner HL
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20768-73. PubMed ID: 21068375
[TBL] [Abstract][Full Text] [Related]
23. The putative endogenous AHR ligand ITE reduces JAG1 and associated NOTCH1 signaling in triple negative breast cancer cells.
Piwarski SA; Thompson C; Chaudhry AR; Denvir J; Primerano DA; Fan J; Salisbury TB
Biochem Pharmacol; 2020 Apr; 174():113845. PubMed ID: 32032581
[TBL] [Abstract][Full Text] [Related]
24. Activation of AHR by ITE improves cardiac remodelling and function in rats after myocardial infarction.
Lin X; Liu W; Chu Y; Zhang H; Zeng L; Lin Y; Kang K; Peng F; Lin J; Huang C; Chai D
ESC Heart Fail; 2023 Dec; 10(6):3622-3636. PubMed ID: 37798907
[TBL] [Abstract][Full Text] [Related]
25. A ligand for the aryl hydrocarbon receptor isolated from lung.
Song J; Clagett-Dame M; Peterson RE; Hahn ME; Westler WM; Sicinski RR; DeLuca HF
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14694-9. PubMed ID: 12409613
[TBL] [Abstract][Full Text] [Related]
26. ITE and TCDD differentially regulate the vascular remodeling of rat placenta via the activation of AhR.
Wu Y; Chen X; Zhou Q; He Q; Kang J; Zheng J; Wang K; Duan T
PLoS One; 2014; 9(1):e86549. PubMed ID: 24475139
[TBL] [Abstract][Full Text] [Related]
27. AhR activation promotes Treg cell generation by enhancing Lkb1-mediated fatty acid oxidation via the Skp2/K63-ubiquitination pathway.
Zhang Q; Zhu Y; Lv C; Fang Y; Liao M; Xia Y; Wei Z; Dai Y
Immunology; 2023 Aug; 169(4):412-430. PubMed ID: 36930164
[TBL] [Abstract][Full Text] [Related]
28. AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice.
Goettel JA; Gandhi R; Kenison JE; Yeste A; Murugaiyan G; Sambanthamoorthy S; Griffith AE; Patel B; Shouval DS; Weiner HL; Snapper SB; Quintana FJ
Cell Rep; 2016 Oct; 17(5):1318-1329. PubMed ID: 27783946
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of the aryl hydrocarbon receptor in ocular Behcet's disease.
Wang C; Ye Z; Kijlstra A; Zhou Y; Yang P
Mediators Inflamm; 2014; 2014():195094. PubMed ID: 25045206
[TBL] [Abstract][Full Text] [Related]
30. Apatinib inhibits glioma cell malignancy in patient-derived orthotopic xenograft mouse model by targeting thrombospondin 1/myosin heavy chain 9 axis.
Yao H; Liu J; Zhang C; Shao Y; Li X; Yu Z; Huang Y
Cell Death Dis; 2021 Oct; 12(10):927. PubMed ID: 34635636
[TBL] [Abstract][Full Text] [Related]
31. A tryptophan derivative, ITE, enhances liver cell metabolic functions in vitro.
Zhang X; Lu J; He B; Tang L; Liu X; Zhu D; Cao H; Wang Y; Li L
Int J Mol Med; 2017 Jan; 39(1):101-112. PubMed ID: 27959388
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide transcriptional profiling of human glioblastoma cells in response to ITE treatment.
Kang B; Zhou Y; Zheng M; Wang YJ
Genom Data; 2015 Sep; 5():281-3. PubMed ID: 26484269
[TBL] [Abstract][Full Text] [Related]
33. An Endogenous Aryl Hydrocarbon Receptor Ligand Induces Preeclampsia-like Phenotypes: Transcriptome, Phosphoproteome, and Cell Functions.
Zhao YJ; Zhou C; Wei YY; Zhang SY; Mishra JS; Li HH; Lei W; Wang K; Kumar S; Zheng J
bioRxiv; 2023 Dec; ():. PubMed ID: 38187714
[TBL] [Abstract][Full Text] [Related]
34. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
35. Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia/reperfusion injury.
Yang Y; Wang N; Xu L; Liu Y; Huang L; Gu M; Wu Y; Guo W; Sun H
Cell Death Dis; 2023 Feb; 14(2):92. PubMed ID: 36754954
[TBL] [Abstract][Full Text] [Related]
36. The emerging roles of AhR in physiology and immunity.
Hao N; Whitelaw ML
Biochem Pharmacol; 2013 Sep; 86(5):561-70. PubMed ID: 23856287
[TBL] [Abstract][Full Text] [Related]
37. Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2.
Yeste A; Takenaka MC; Mascanfroni ID; Nadeau M; Kenison JE; Patel B; Tukpah AM; Babon JA; DeNicola M; Kent SC; Pozo D; Quintana FJ
Sci Signal; 2016 Jun; 9(433):ra61. PubMed ID: 27330188
[TBL] [Abstract][Full Text] [Related]
38. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.
Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M
Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818
[TBL] [Abstract][Full Text] [Related]
39. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation.
Li Y; Wang K; Jiang YZ; Chang XW; Dai CF; Zheng J
Cell Oncol (Dordr); 2014 Dec; 37(6):429-37. PubMed ID: 25404385
[TBL] [Abstract][Full Text] [Related]
40. ITE promotes hypoxia-induced transdifferentiation of human pulmonary arterial endothelial cells possibly by activating transforming growth factor-β/Smads and MAPK/ERK pathways.
Wang J; Yan G; Guo H; Zhu Y; Shui X; He Y; Chen C; Lei W
J Cell Biochem; 2019 Dec; 120(12):19567-19577. PubMed ID: 31297875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]